Citadel Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-443,189
| Closed | -$10.6M | – | 7543 |
|
|
2021
Q1 | $10.6M | Buy |
443,189
+332,232
| +299% | +$7.94M | ﹤0.01% | 1389 |
|
|
2020
Q4 | $1.62M | Sell |
110,957
-293,343
| -73% | -$4.28M | ﹤0.01% | 2793 |
|
|
2020
Q3 | $5.74M | Sell |
404,300
-96,441
| -19% | -$1.37M | ﹤0.01% | 1418 |
|
|
2020
Q2 | $7.37M | Buy |
500,741
+474,989
| +1,844% | +$6.99M | ﹤0.01% | 1259 |
|
|
2020
Q1 | $106K | Sell |
25,752
-138,459
| -84% | -$570K | ﹤0.01% | 4338 |
|
|
2019
Q4 | $790K | Sell |
164,211
-205,304
| -56% | -$988K | ﹤0.01% | 3195 |
|
|
2019
Q3 | $2.24M | Buy |
369,515
+85,450
| +30% | +$518K | ﹤0.01% | 2283 |
|
|
2019
Q2 | $1.84M | Sell |
284,065
-12,320
| -4% | -$80K | ﹤0.01% | 2473 |
|
|
2019
Q1 | $2.1M | Buy |
296,385
+171,386
| +137% | +$1.22M | ﹤0.01% | 2286 |
|
|
2018
Q4 | $607K | Buy |
124,999
+105,198
| +531% | +$511K | ﹤0.01% | 3150 |
|
|
2018
Q3 | $145K | Sell |
19,801
-106,983
| -84% | -$783K | ﹤0.01% | 3834 |
|
|
2018
Q2 | $808K | Buy |
126,784
+60,991
| +93% | +$389K | ﹤0.01% | 2821 |
|
|
2018
Q1 | $358K | Sell |
65,793
-14,816
| -18% | -$80.6K | ﹤0.01% | 3151 |
|
|
2017
Q4 | $336K | Sell |
80,609
-7,534
| -9% | -$31.4K | ﹤0.01% | 3071 |
|
|
2017
Q3 | $848K | Sell |
88,143
-849,194
| -91% | -$8.17M | ﹤0.01% | 2385 |
|
|
2017
Q2 | $11.1M | Buy |
937,337
+153,572
| +20% | +$1.82M | 0.01% | 813 |
|
|
2017
Q1 | $10M | Buy |
783,765
+402,832
| +106% | +$5.16M | 0.01% | 884 |
|
|
2016
Q4 | $4.66M | Buy |
380,933
+285,106
| +298% | +$3.49M | ﹤0.01% | 1096 |
|
|
2016
Q3 | $1.13M | Buy |
+95,827
| New | +$1.13M | ﹤0.01% | 1886 |
|
|
2013
Q4 | – | Sell |
-420,401
| Closed | -$5.11M | – | 3264 |
|
|
2013
Q3 | $5.11M | Buy |
+420,401
| New | +$5.11M | 0.01% | 937 |
|